메뉴 건너뛰기




Volumn 125, Issue 3, 2000, Pages 617-634

Modelling rubella in Europe

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; RUBELLA ANTIBODY; RUBELLA VACCINE;

EID: 0034487371     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268800004660     Document Type: Article
Times cited : (61)

References (24)
  • 1
    • 0022619946 scopus 로고
    • Quantitative investigations of different rubella vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom
    • (1986) J Hyg , vol.96 , pp. 305-333
    • Anderson, R.M.1    Grenfell, B.T.2
  • 2
    • 0003677583 scopus 로고
    • Infectious diseases of humans: Dynamics and control
    • Oxford: Oxford University Press
    • (1991)
    • Anderson, R.M.1    May, R.M.2
  • 13
    • 0003262226 scopus 로고    scopus 로고
    • Analysis of seroprevalence data for measles, mumps and rubella in six. European countries: Estimation of MMR vaccine coverage and prevalence of past infection
    • In press
    • (2000) Epidemiol Infect
    • Gay, N.J.1
  • 14
    • 0028593441 scopus 로고
    • Childhood vaccination coverage in Italy: Results of a seven-region survey
    • The Italian Vaccine Coverage Survey Working Group.
    • (1994) Bull WHO , vol.72 , pp. 885-895
  • 18
  • 19
    • 0029869595 scopus 로고    scopus 로고
    • Rubella immunity and morbidity: Impact of different vaccination programs in Finland 1979-1992
    • (1996) Scand J Infect Dis , vol.28 , pp. 31-35
    • Ukkonen, P.1
  • 21
    • 0031556988 scopus 로고    scopus 로고
    • The epidemiology of rubella in England and Wales before and after the 1994 measles-rubella vaccination campaign: Fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme
    • (1997) CDR , vol.7
    • Miller, E.1    Waight, P.A.2    Gay, N.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.